Form 10-Q
Table of Contents

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 10-Q

 

 

(Mark one)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2009

OR

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                      to                     

Commission File Number 001-33747

 

 

METAVANTE TECHNOLOGIES, INC.

(Exact name of registrant as specified in its charter)

 

Wisconsin   39-0968604
(State of incorporation)   (I.R.S. Employer Identification No.)
4900 West Brown Deer Road, Milwaukee Wisconsin   53223
(Address of principal executive offices)   (Zip code)

(414) 357-2290

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

Indicate by check mark whether the registrant has submitted electronically and posted on it corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ¨ No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large accelerated filer  x   Accelerated filer  ¨
Non-accelerated filer  ¨   Smaller reporting company  ¨
(Do not check if a smaller reporting company)  

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) Yes ¨ No x

Indicate the number of shares outstanding of each of the registrant’s classes of common stock, as of the latest practicable date:

 

Class

 

Outstanding at August 4, 2009

Common Stock, $0.01 par value

  120,691,747 shares

 

 

 


Table of Contents

TABLE OF CONTENTS

 

          Page

Part I: Financial Information

  

Item 1.

   Financial Statements    1
   Unaudited Condensed Consolidated Balance Sheets – June 30, 2009 and December 31, 2008    1
   Unaudited Condensed Consolidated Statements of Income – Three and Six Months Ended June 30, 2009 and June 30, 2008    2
   Unaudited Condensed Consolidated Statements of Cash Flows – Six Months Ended June 30, 2009 and June 30, 2008    3
   Notes to Unaudited Condensed Consolidated Financial Statements    4

Item 2.

   Management’s Discussion and Analysis of Financial Condition and Results of Operations    16

Item 3.

   Quantitative and Qualitative Disclosures About Market Risk    27

Item 4.

   Controls and Procedures    27

Part II: Other Information

  

Item 1A.

   Risk Factors    28

Item 5.

   Other Information    28

Item 6.

   Exhibits    28
   Signatures    29
   Exhibit Index    30

 

i


Table of Contents

PART I. FINANCIAL INFORMATION

 

Item 1. Financial Statements.

METAVANTE TECHNOLOGIES, INC.

Condensed Consolidated Balance Sheets (Unaudited)

(In thousands)

 

     June 30,
2009
    December 31,
2008
 

Assets

    

Current Assets:

    

Cash and cash equivalents

   $ 362,610      $ 268,781   

Restricted funds

     217,936        404,155   

Accounts receivable, net

     111,775        135,783   

EFD processing receivables

     72,817        78,995   

Unbilled revenues

     109,599        120,351   

Deferred income taxes

     33,700        33,821   

Other current assets

     50,827        57,102   
                

Total current assets

     959,264        1,098,988   

Capitalized software and conversions, net

     270,406        258,300   

Premises and equipment, net

     130,450        136,003   

Goodwill and other intangibles, net

     1,564,695        1,570,430   

Other assets

     113,326        93,251   
                

Total

   $ 3,038,141      $ 3,156,972   
                

Liabilities and Shareholders’ Equity

    

Current Liabilities:

    

Current maturities of long-term debt

   $ 17,500      $ 17,500   

Accounts payable

     23,217        28,279   

Accrued compensation and related benefits

     30,519        48,469   

Accrued expenses

     161,929        160,849   

Payments held for third party remittance

     213,602        402,252   

Deferred revenues

     134,428        158,288   

Other current liabilities

     10,524        9,489   
                

Total current liabilities

     591,719        825,126   

Long-term debt

     1,710,625        1,719,380   

Deferred income taxes

     144,467        140,655   

Other long-term liabilities

     72,064        95,358   
                

Total liabilities

     2,518,875        2,780,519   

Commitments and Contingencies—See Note 12

    

Shareholders’ Equity:

    

Preferred stock, $0.01 par value-authorized, 5,000 shares; no shares issued

     —          —     

Common stock, $0.01 par value-authorized, 200,000 shares; issued and outstanding, 120,260 and 119,815 shares, respectively

     1,203        1,198   

Treasury stock, at cost, 0 and 37 shares, respectively

     —          (650

Additional paid-in capital

     1,496,749        1,482,634   

Retained deficit

     (931,428     (1,023,542

Accumulated other comprehensive income

     (62,731     (98,613

Noncontrolling interest—See Note 1

     15,473        15,426   
                

Total shareholders’ equity

     519,266        376,453   
                

Total

   $ 3,038,141      $ 3,156,972   
                

See notes to condensed consolidated financial statements

 

1


Table of Contents

METAVANTE TECHNOLOGIES, INC.

Condensed Consolidated Statements of Income (Unaudited)

(In thousands, except per share amounts)

 

     Three Months Ended
June 30,
    Six Months Ended
June 30,
 
     2009     2008     2009     2008  

Processing and services revenue

   $ 440,264      $ 424,828      $ 867,114      $ 849,392   

Expenses:

        

Cost of processing and services

     277,132        279,541        557,391        560,189   

Selling, general and administrative

     53,878        60,802        111,016        119,526   
                                

Total expenses

     331,010        340,343        668,407        679,715   
                                

Income from operations

     109,254        84,485        198,707        169,677   

Other non-operating income (expense):

        

Interest income

     116        533        226        1,353   

Interest expense

     (28,460     (25,690     (54,629     (54,181

Net loss related to Firstsource

     —          (324     —          (886

Other

     266        (909     93        (717
                                

Income before income taxes and noncontrolling interest

     81,176        58,095        144,397        115,246   

Provision for income taxes

     29,925        21,834        53,462        44,313   
                                

Net income before noncontrolling interest

     51,251        36,261        90,935        70,933   

Noncontrolling interest—See Note 1

     608        639        1,179        939   
                                

Net income

   $ 51,859      $ 36,900      $ 92,114      $ 71,872   
                                

Net earnings per share:

        

Basic

   $ 0.43      $ 0.31      $ 0.77      $ 0.60   

Diluted

   $ 0.43      $ 0.31      $ 0.76      $ 0.60   

Weighted average shares:

        

Basic

     119,721        119,074        119,574        119,038   

Diluted

     121,420        120,139        120,600        120,015   

 

 

See notes to condensed consolidated financial statements

 

2


Table of Contents

METAVANTE TECHNOLOGIES, INC.

Condensed Consolidated Statements of Cash Flows (Unaudited)

(In thousands)

 

     Six Months Ended
June 30,
 
     2009     2008  

Operating Activities:

    

Net income

   $ 92,114      $ 71,872   

Adjustments to reconcile net income to net cash from operating activities:

    

Depreciation of premises and equipment

     18,426        19,706   

Amortization

     55,135        55,035   

Amortization of debt issuance costs

     3,073        3,689   

Deferred income taxes

     (442     (15

Stock-based compensation expense

     5,987        7,510   

Other non-cash items

     (627     (2,349

Net loss related to Firstsource

     —          886   

Changes in assets and liabilities—net of effect from acquisitions of businesses and foreign currency adjustments:

    

Accounts receivable

     24,468        (955

EFD processing receivables

     6,170        9,446   

Unbilled revenues

     10,706        (1,743

Other assets

     3,220        (731

Accounts payable and accrued liabilities

     (27,567     (18,148

Deferred revenues

     (23,890     421   

Other liabilities

     3,681        3,692   
                

Net cash from operating activities

     170,454        148,316   
                

Investing Activities:

    

Capital expenditures for premises and equipment

     (11,855     (9,421

Capital expenditures for capitalized software and conversion costs

     (50,796     (56,368

Change in restricted funds

     186,219        (75,022

Acquisitions—net of cash acquired

     (11,032     (68,265
                

Net cash from investing activities

     112,536        (209,076
                

Financing Activities:

    

Repayment of debt and capital lease obligations

     (8,755     (4,382

Change in payments held for third party remittance

     (188,650     75,622   

Proceeds from stock options and stock purchase right

     7,587        2,475   
                

Net cash from financing activities

     (189,818     73,715   

Effect of exchange rate changes on cash and cash equivalents

     657        (712
                

Change in cash and cash equivalents

     93,829        12,243   

Cash and cash equivalents— beginning of period

     268,781        185,528   
                

Cash and cash equivalents— end of period

   $ 362,610      $ 197,771   
                

Supplemental Cash Flow Information

    

Cash paid in the period for:

    

Interest

   $ 43,410      $ 52,050   
                

Income taxes

   $ 39,981      $ 43,738   
                

See notes to condensed consolidated financial statements

 

3


Table of Contents

METAVANTE TECHNOLOGIES, INC.

Notes to the Condensed Consolidated Financial Statements (Unaudited)

(In thousands, except per share amounts)

 

1. Basis of Presentation and Summary of Significant Accounting Policies

The accompanying condensed consolidated financial statements of Metavante Technologies, Inc. (“Metavante” or the “Company”) for the three and six months ended June 30, 2009 and 2008 are unaudited. In the opinion of management, all adjustments, normal and recurring in nature, necessary for the fair presentation of such condensed consolidated financial statements have been included. Such interim results are not necessarily indicative of full year results. The condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial reporting, and with the instructions of Form 10-Q and Article 10 of Regulation S-X and accordingly they do not include all of the information and footnotes required in the annual consolidated financial statements and accompanying footnotes. The condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and accompanying notes included in Metavante’s Annual Report on Form 10-K for the year ended December 31, 2008.

The condensed consolidated balance sheet at December 31, 2008 has been derived from the audited consolidated balance sheet at that date, but does not include all of the information and footnotes required by United States generally accepted accounting principles for complete financial statements.

The condensed consolidated financial statements include the accounts of Metavante, its wholly-owned subsidiaries, and subsidiaries that are majority-owned and/or over which it exercised substantive control. Investments in unconsolidated affiliates, in which Metavante has 20 percent to 50 percent of ownership interest and has the ability to exercise significant influence, but not substantive control, over the affiliate’s operating and financial policies, are accounted for using the equity method of accounting. All intercompany transactions are eliminated in consolidation.

Noncontrolling Interest

As of January 1, 2009, Metavante adopted the requirements of Financial Accounting Standards Board (“FASB”) Statement of Financial Accounting Standards (“SFAS”) No. 160, “Noncontrolling Interests in Consolidated Financial Statements—an amendment of ARB No. 51” (“SFAS 160”). Noncontrolling interest is the portion of equity in a subsidiary not attributable, directly or indirectly, to a parent. SFAS 160 requires that Metavante report noncontrolling interest as a component of shareholders’ equity within the Condensed Consolidated Balance Sheets. The Condensed Consolidated Statements of Income include the noncontrolling interest’s proportionate share of the earnings and losses of the subsidiaries, net of dividends. The prior period financial statements have been adjusted to reflect the reporting requirements of SFAS 160. See Note 7 for changes in noncontrolling interest during the six months ended June 30, 2009.

Subsequent Events

As of June 30, 2009, Metavante adopted FASB SFAS No. 165, “Subsequent Events” (“SFAS 165”). SFAS 165 establishes general standards and requirements for and disclosure of events that occur after the balance sheet date but before financial statements are issued or are available to be issued. It requires the disclosure of the date through which an entity had evaluated subsequent events and the basis for that date, that is, whether that date represents the date the financial statements were issued or were available to be issued. Metavante evaluated subsequent events through August 5, 2009, which is the date the financial statements were issued.

2. New Accounting Pronouncements

As of January 1, 2009, Metavante adopted the provisions of FASB SFAS 141(R), “Business Combinations” (“SFAS 141(R)”). SFAS 141(R) requires Metavante to recognize all assets acquired and liabilities assumed and any noncontrolling interest in the acquiree at fair value as of the date of the business combination. This includes the measurement of the acquirer’s shares issued in consideration for a business combination, the recognition of contingent consideration, the recognition of capitalized in-process research and development, the accounting for acquisition-related restructuring cost accruals, the treatment of acquisition related transaction costs and the recognition of changes in the acquirer’s income tax valuation allowance and deferred taxes. The adoption of SFAS 141(R) did not have a material impact on Metavante’s financial statements, but may have a significant future impact on Metavante depending on the nature and type of future business combinations.

 

4


Table of Contents

METAVANTE TECHNOLOGIES, INC.

Notes to the Condensed Consolidated Financial Statements – continued (Unaudited)

(In thousands, except per share amounts)

 

As of January 1, 2009, Metavante adopted FASB SFAS No. 161, “Disclosures about Derivative Instruments and Hedging Activities – an amendment of FASB Statement No. 133” (“SFAS 161”). SFAS 161 amended and expanded the disclosure requirements related to derivative instruments, with the intent to provide users of financial statements with an enhanced understanding of how and why an entity uses derivative instruments and how derivative instruments and related hedged items affect an entity’s financial position, financial performance and cash flows. See Note 6 for SFAS 161 disclosure requirements related to derivative instruments held by Metavante.

As of January 1, 2009, Metavante adopted Emerging Issues Task Force (“EITF”) Issue No. 08-6, “Equity Method Investment Accounting Considerations” (“EITF 08-6”). EITF 08-6 provided consensus on the application of certain equity method accounting guidance including initial measurement, decrease in investment value, and change in level of ownership or degree of influence. The adoption of EITF 08-6 did not have a material impact on Metavante’s financial statements.

As of April 1, 2009, Metavante adopted FASB Staff Position (“FSP”) No. FAS 115-2 and FAS 124-2, “Recognition and Presentation of Other-Than-Temporary Impairments” (“FSP FAS 115-2 and FAS 124-2”). FSP FAS 115-2 and FAS 124-2 amended the other-than-temporary guidance in United States GAAP for debt securities to make the guidance more operational and to improve the presentation and disclosure of other-than-temporary impairment on securities in the financial statements. It did not amend existing recognition and measurement guidance related to other-than-temporary impairments of equity securities. The adoption of FSP FAS 115-2 and FAS 124-2 did not have a material impact on Metavante’s financial statements.

As of April 1, 2009, Metavante adopted FSP No. FAS 157-4, “Determining Fair Value When the Volume and Level of Activity for the Asset or Liability Have Significantly Decreased and Identifying Transactions That Are Not Orderly” (“FSP FAS 157-4”). FSP FAS 157-4 provided additional guidance for estimating fair value in accordance with FASB Statement No. 157, “Fair Value Measurements”, when the volume and level of activity for the asset or liability have significantly decreased. The adoption of FSP FAS 157-4 did not have a material impact on Metavante’s financial statements.

As of April 1, 2009, Metavante adopted FSP No. FAS 107-1 and APB 28-1, “Interim Disclosures about Fair Value of Financial Instruments” (“FSP FAS 107-1 and APB 28-1”). FAS 107-1 and APB 28-1 amended FASB Statement No. 107, “Disclosures about Fair Value of Financial Instruments,” to require disclosure about fair value of financial instruments for interim reporting periods. See Note 6 and Note 10 for FSP FAS 107-1 and APB 28-1 disclosure requirements related to Metavante.

In June 2009, the FASB issued SFAS No. 166, “Accounting for Transfers of Financial Assets – an amendment of FASB Statement No. 140” (“SFAS 166”). SFAS 166 is intended to improve the relevance, representational faithfulness, and comparability of the information that a reporting entity provides in its financial statements about a transfer of financial assets; the effects of a transfer on its financial position, financial performance, and cash flows; and a transferor’s continuing involvement, if any, in transferred financial assets. In addition, SFAS 166 eliminates the concept of a qualifying special purpose entity and modifies the derecognition provisions in SFAS No. 140. SFAS 166 is effective for Metavante on January 1, 2010 and is to be applied prospectively. Early adoption is prohibited. Metavante does not believe that the adoption of SFAS 166 will have a material impact on Metavante’s financial statements.

In June 2009, the FASB issued SFAS No. 167, “Amendments to FASB Interpretation No. 46(R)” (“SFAS 167”). SFAS 167 amends the consolidation guidance applicable to variable interest entities. The amendments will significantly affect the overall consolidation analysis under FASB Interpretation No. 46(R). SFAS 167 is effective for Metavante on January 1, 2010 and is to be applied prospectively. Early adoption is prohibited. Metavante does not believe that the adoption of SFAS 167 will have a material impact on Metavante’s financial statements.

In June 2009, the FASB issued SFAS 168, “The FASB Accounting Standards Codification TM and the Hierarchy of General Accepted Accounting Principles – a replacement of FASB Statement No. 162” (“SFAS 168”). SFAS 168 identifies the sources of accounting principles and the framework for selecting the principles used in the preparation of financial statements of nongovernmental entities that are presented in conformity with generally accepted accounting principles in the United States. This statement establishes the FASB Accounting Standards Codification TM as the source of authoritative accounting principles recognized by the FASB. Rules and interpretive releases of the Securities and Exchange Commission (“SEC”) under authority of federal securities laws are also sources of authoritative accounting principles generally accepted in the United States for SEC registrants. SFAS 168 is effective for Metavante on July 1, 2009. The adoption of SFAS 168 will not have a material impact on Metavante’s financial statements.

 

5


Table of Contents

METAVANTE TECHNOLOGIES, INC.

Notes to the Condensed Consolidated Financial Statements – continued (Unaudited)

(In thousands, except per share amounts)

 

3. Investments

Metavante holds a 20.0% interest in the common stock of Firstsource Solutions Limited (“Firstsource”), an India-based provider of business process outsourcing solutions. Metavante and two other shareholders own a combined 68% of Firstsource.

Firstsource’s common stock is publicly traded on the National Stock Exchange of India Limited (“NSE”). As of June 30, 2009 and December 31, 2008, Metavante recorded its interest in the common stock of Firstsource in accordance with SFAS 115, “Accounting for Certain Investments in Debt and Equity Securities” (“SFAS 115”) because the fair value is readily determinable from price quotations available from the NSE. Metavante classified its interest in Firstsource as an available-for-sale investment in accordance with SFAS 115. Metavante’s interest in Firstsource was recorded at its readily determinable fair value, with unrealized gains and losses recorded in other comprehensive income (loss) until realized. As of June 30, 2009 and December 31, 2008, Metavante’s interest in Firstsource was summarized as follows:

 

     Carrying
Value
   Gross    Estimated
Fair
Value
      Unrealized
Gains
   Unrealized
Losses
  

June 30, 2009

   $ 75,312    $ —      $ 31,681    $ 43,631
                           

December 31, 2008

   $ 75,312    $ —      $ 52,778    $ 22,534
                           

This investment was included in Other Assets on the Condensed Consolidated Balance Sheets. During the three and six months ended June 30, 2009, Metavante recorded an unrealized gain of $18,030 and $21,097, respectively, in other comprehensive income (“OCI”) related to its interest in Firstsource. The unrealized gain during the three and six months ended June 30, 2009 resulted from an increase in Firstsource’s publicly traded stock price from March 31, 2009 to June 30, 2009 and December 31, 2008 to June 30, 2009, respectively. Metavante did not sell any portion of its investment in Firstsource during the three and six months ended June 30, 2009 and 2008.

As of June 30, 2009, Metavante assessed its interest in Firstsource for impairment in accordance with SFAS 115 and FSP Nos. 115-1 and 124-1, “The Meaning of Other-Than-Temporary Impairment and its Application to Certain Investments”. In order to assess whether the decline in fair value below the carrying value of Firstsource was temporary or not, Metavante evaluated the following factors: 1) Firstsource’s reported and projected financial results have not changed significantly despite the economic downturn, 2) Metavante calculated a fair value of Firstsource utilizing a discounted cash flow model premised on these projected financial results that exceeded Metavante’s carrying value of its investment, 3) the recent economic environment caused the Indian stock market to decrease for reasons not related to Firstsource’s operating results, 4) Metavante does not consider the length of time that Firstsource’s market value has been below the carrying value to be adequate to conclude that the market value of Firstsource will not recover to its carrying value, 5) the increase in Firstsource’s publicly traded stock price from December 31, 2008 to June 30, 2009, and 6) Metavante has the intent and ability to hold its interest in Firstsource for a sufficient period of time to allow for a recovery of Firstsource’s market value or the exploration of various options in realizing the value of Firstsource. Based on the outcome of Metavante’s evaluation, Metavante determined Firstsource’s stock price is not other-than-temporary and an impairment charge was not recorded during the three and six months ended June 30, 2009. The above factors and operating results of Firstsource will continue to be monitored closely to ensure the fair value calculated using the discounted cash flow model remains above Metavante’s carrying value. An unfavorable change in Firstsource’s underlying operating results, the market value of Firstsource remaining at its current level for an extended period of time, or an event that determines a different valuation could result in Metavante concluding the impairment is other-than-temporary.

For the three and six months ended June 30, 2008, when the investment in Firstsource was accounted for under the equity method of accounting, Metavante was under the provisions of SEC Staff Accounting Bulletin No. 51, “Accounting for Sales of Stock by a Subsidiary” (“SAB 51”), which states when an investee issues shares of its common stock, the investor should recognize a gain or loss in the same manner as if the investor has sold a portion of its investment. Subject to certain criteria of SAB 51, the resulting gain or loss can be recognized in the consolidated income statements or reflected as a capital transaction in consolidated shareholders’ equity at the option of Metavante, and the accounting treatment selected is to be

 

6


Table of Contents

METAVANTE TECHNOLOGIES, INC.

Notes to the Condensed Consolidated Financial Statements – continued (Unaudited)

(In thousands, except per share amounts)

 

followed consistently for all future gains or losses. Metavante elected to recognize all SAB 51 gains or losses in the consolidated statement of income. Metavante recognized a net loss of $324 and $886 for the three and six months ended June 30, 2008, respectively, as a result of Firstsource’s equity transactions.

4. Goodwill and Other Intangibles

The changes in the carrying amount of goodwill by segment for the six months ended June 30, 2009, were as follows:

 

     Financial
Solutions
Group
   Payment
Solutions
Group
   Total

Goodwill balance as of December 31, 2008

   $ 400,802    $ 909,300    $ 1,310,102

Goodwill acquired during the period

     —        —        —  

Purchase accounting adjustments

     —        6,630      6,630
                    

Goodwill balance as of June 30, 2009

   $ 400,802    $ 915,930    $ 1,316,732
                    

Purchase accounting adjustments are the adjustments to the initial goodwill recorded at the time an acquisition is completed. Such adjustments generally consist of adjustments to the assigned fair value of the assets acquired and liabilities assumed resulting from the completion of valuations, the reduction of goodwill allocated to sales transactions, and corresponding foreign currency translation adjustments. For the six months ended June 30, 2009, the adjustments to goodwill primarily represent foreign currency translation adjustments and contingent consideration related to business combinations completed prior to the adoption of SFAS 141(R). For the six months ended June 30, 2009, Metavante paid $9,052 of contingent consideration.

SFAS No. 142, “Goodwill and Other Intangibles” (“SFAS 142”) provides specific guidance for testing goodwill and indefinite lived intangible assets for impairment. Goodwill is tested for impairment at least annually using a two-step process that begins with an estimation of fair value at the “reporting unit” level. Metavante’s reporting units are businesses one level below the operating segment level for which discrete financial information is prepared and regularly reviewed by management. The first step screens for potential impairment and the second measures the amount of the impairment. In accordance with SFAS 142, Metavante performed its annual test for impairment as of June 30, 2009, and concluded that there was no impairment.

Metavante adopted the provisions of FSP No. 142-3, “Determination of the Useful Life of Intangible Assets” (“FSP FAS 142-3”) as of January 1, 2009. FSP FAS 142-3 amends the factors that should be considered in developing renewal or extension assumptions used to determine the useful life of a recognized intangible asset under SFAS 142. More specifically, FSP FAS 142-3 removes the requirement under paragraph 11 of SFAS 142 to consider whether an intangible asset can be renewed without substantial cost or material modifications to the existing terms and conditions and instead, requires an entity to consider its own historical experience in renewing similar arrangements. The adoption of FSP FAS 142-3 did not have a material impact on Metavante’s financial statements.

 

7


Table of Contents

METAVANTE TECHNOLOGIES, INC.

Notes to the Condensed Consolidated Financial Statements – continued (Unaudited)

(In thousands, except per share amounts)

 

As of June 30, 2009 and December 31, 2008, Metavante’s other intangible assets consisted of the following:

 

June 30, 2009

   Gross
Carrying
Value
   Accumulated
Amortization
    Net
Carrying
Value

Customer Relationships

   $ 353,406    $ (113,164   $ 240,242

Other

     13,555      (5,834     7,721
                     

Total

   $ 366,961    $ (118,998   $ 247,963
                     

December 31, 2008

   Gross
Carrying
Value
   Accumulated
Amortization
    Net
Carrying
Value

Customer Relationships

   $ 352,779    $ (100,692   $ 252,087

Other

     13,555      (5,314     8,241
                     

Total

   $ 366,334    $ (106,006   $ 260,328
                     

Amortization expense of other intangible assets amounted to $7,381 and $7,610 for the three months ended June 30, 2009 and 2008, respectively. Amortization expense of other intangible assets amounted to $14,733 and $14,868 for the six months ended June 30, 2009 and 2008, respectively.

The estimated amortization expense of other intangible assets for the next five years is:

 

Remainder of 2009

   $ 14,755

2010

     29,413

2011

     29,087

2012

     27,890

2013

     26,619

5. Debt and Capital Lease Obligations

Debt and capital lease obligations at June 30, 2009 and December 31, 2008, consisted of the following:

 

     June 30,
2009
    December 31,
2008
 

Term loan

   $ 1,728,125      $ 1,736,875   

Capital lease obligations

     —          5   
                

Total debt and capital lease obligations

     1,728,125        1,736,880   

Less current maturities

     (17,500     (17,500
                

Total long-term debt and capital lease obligations

   $ 1,710,625      $ 1,719,380   
                

The term loan carries interest at three-month LIBOR plus a margin of 1.75%. As of June 30, 2009 and December 31, 2008, the interest rate on the term loan was 2.78% and 4.94%, respectively.

6. Interest Rate Swaps

Metavante is subject to interest rate market risks in connection with Metavante’s variable-rate long-term debt and has entered into interest swaps to mitigate the risk. SFAS No. 133, “Accounting for Derivative Instruments and Hedging Activities” (“SFAS 133”), requires Metavante to recognize derivative instruments as either assets or liabilities in the Condensed Consolidated Balance Sheets at their fair value. Metavante has designated all of its interest rate swaps as cash flow hedges in accordance with SFAS 133. Changes in the fair value of an interest rate swap that qualifies as a cash flow hedge are recorded in other comprehensive income and are reclassified into earnings when the forecasted transaction affects earnings. Gains and losses on the interest rate swaps representing either hedge ineffectiveness or hedge components excluded in the assessment of effectiveness would be recognized in current earnings.

 

8


Table of Contents

METAVANTE TECHNOLOGIES, INC.

Notes to the Condensed Consolidated Financial Statements – continued (Unaudited)

(In thousands, except per share amounts)

 

Interest rate swaps as of June 30, 2009 are summarized as follows:

On November 26, 2007, Metavante entered into an amortizing interest rate swap with an effective date of February 1, 2008 and a maturity date of February 1, 2012. The swap has a notional value of $600,000 through February 1, 2010; $400,000 through February 1, 2011; and $200,000 through February 1, 2012. The interest rate swap relates to $600,000 of the term loan. Under the terms of the swap, Metavante is to receive variable interest at the three-month LIBOR rate, and Metavante is to pay the counterparty a fixed rate of 3.865%. The swap effectively fixes Metavante’s rate on $600,000 of the term loan facility at 5.615%. Metavante designated the interest rate swap as a cash flow hedge in accordance with SFAS 133.

On January 30, 2008, Metavante entered into an interest rate swap with a notional value of $200,000, an effective date of February 1, 2008 and a maturity date of February 1, 2012. The interest rate swap relates to $200,000 of the term loan. Under the terms of the swap, Metavante is to receive variable interest at the three-month LIBOR rate, and Metavante is to pay the counterparty a fixed rate of 3.436%. This swap effectively fixes Metavante’s rate on an additional $200,000 of the term loan facility at 5.186%. Metavante designated this swap as a cash flow hedge in accordance with SFAS 133.

On October 30, 2008, Metavante entered into interest rate swaps with a total notional value of $900,000, an effective date of November 1, 2008 and a maturity date of February 1, 2010. The interest rate swaps relate to $900,000 of the term loan. Under the terms of the swaps, Metavante is to receive variable interest at the three-month LIBOR rate, and Metavante is to pay the counterparties a fixed rate of 2.598%. These swaps effectively fix Metavante’s rate on an additional $900,000 of the term loan facility at 4.348%. Metavante designated these swaps as cash flow hedges in accordance with SFAS 133.

The table below summarizes Metavante’s interest rate swaps designated as cash flow hedges in accordance with SFAS 133 as of June 30, 2009 and December 31, 2008:

 

     Notional
Amount
   June 30, 2009     December 31, 2008  

Date Entered

      Balance Sheet
Location
   Fair Value     Balance Sheet
Location
   Fair Value  

November 2007

   $ 600,000    Other long-term
liabilities
   $ (22,071   Other long-term
liabilities
   $ (28,479

January 2008

     200,000    Other long-term
liabilities
     (7,966   Other long-term
liabilities
     (10,148

October 2008

     900,000    Other current
liabilities
     (9,824   Other long-term
liabilities
     (10,901
                             

Total

   $ 1,700,000       $ (39,861      $ (49,528
                             

 

9


Table of Contents

METAVANTE TECHNOLOGIES, INC.

Notes to the Condensed Consolidated Financial Statements – continued (Unaudited)

(In thousands, except per share amounts)

 

The table below summarizes the gains on interest rate swaps designated as cash flow hedges in accordance with SFAS 133 in other comprehensive income for the six months ended June 30, 2009:

 

Date Entered

   Notional
Amount
   Amount of gain
recognized in OCI
(effective portion),
net of tax

November 2007

   $ 600,000    $ 3,941

January 2008

     200,000      1,342

October 2008

     900,000      662
             

Total

   $ 1,700,000    $ 5,945
             

Metavante recognized no ineffectiveness related to its cash flow hedges for the three and six months ended June 30, 2009 and 2008. During the three and six months ended June 30, 2009, Metavante recognized $8,995 and $14,392, respectively, of interest expense related to its cash flow hedges. Metavante’s estimated net amount recorded in other comprehensive income that is expected to be reclassified into earnings within the next twelve months is $18,919, net of tax. The amount to be reclassified to earnings in the next twelve months will result from the expected cash settlements in accordance with the terms of the interest rate swaps.

7. Shareholders’ Equity

The table below summarizes the changes in shareholders’ equity for the six months ended June 30, 2009:

 

     Compre-
hensive
Income
    Common Stock    Treasury
Stock
    Additional
Paid-in
Capital
   Retained
Earnings
(Deficit)
    Accumulated Other
Comprehensive
Income (Loss)
    Non-controlling
Interest
    Total
Shareholders’
Equity
 
                    
                    
       Shares    Amount              

Balance at December 31, 2008

     119,815    $ 1,198    $ (650   $ 1,482,634    $ (1,023,542   $ (98,613   $ 15,426      $ 376,453   

Net income

   $ 92,114      —        —        —          —        92,114            92,114   

Currency translation adjustment

     7,892      —        —        —          —        —          7,892        —          7,892   

Fair value adjustments on cash flow hedges, net of tax (See Note 6)

     5,945      —        —        —          —        —          5,945        —          5,945   

Amortization of de-designated cash flow hedge, net of tax

     1,046      —        —        —          —        —          1,046        —          1,046   

Unrealized gain on available-for- sale investment

     21,097      —        —        —          —        —          21,097        —          21,097   

Change in unrecognized postretirement gains, net of tax

     (98   —        —        —          —        —          (98     —          (98
                           

Comprehensive income

   $ 127,996                      
                           

Noncontrolling interest share of earnings

     —        —        —          —        —          —          (1,179     (1,179

Capital contribution

     —        —        —          —        —          —          1,226        1,226   

Stock based compensation expense

     —        —        —          5,987      —          —          —          5,987   

Treasury stock activity

     —        —        650        545      —          —          —          1,195   

Stock option and stock purchase right exercises

     445      5      —          7,583      —          —          —          7,588   
                                                             

Balance at June 30, 2009

     120,260    $ 1,203    $ —        $ 1,496,749    $ (931,428   $ (62,731   $ 15,473      $ 519,266   
                                                             

During the three months ended June 30, 2009, Metavante transferred treasury shares to Metavante’s Employee Stock Purchase Plan (the “ESPP”) to settle a portion of the regular quarterly ESPP purchase.

 

10


Table of Contents

METAVANTE TECHNOLOGIES, INC.

Notes to the Condensed Consolidated Financial Statements – continued (Unaudited)

(In thousands, except per share amounts)

 

8. Earnings Per Share

The following table sets forth the computation of basic and diluted earnings per share for the three and six months ended June 30, 2009 and 2008:

 

     Three Months Ended June 30, 2009    Six Months Ended June 30, 2009
     Net Income
(Numerator)
   Average
Shares
(Denominator)
   Per
Share
Amount
   Net Income
(Numerator)
   Average
Shares
(Denominator)
   Per
Share
Amount

Basic earnings per share:

                 

Income available to common shareholders

   $ 51,859    119,721    $ 0.43    $ 92,114    119,574    $ 0.77
                         

Effect of dilutive securities:

                 

Stock options, restricted stock and other plans

      1,432          880   

Stock purchase right

      267          146   
                             

Diluted earnings per share:

                 

Income available to common shareholders

   $ 51,859    121,420    $ 0.43    $ 92,114    120,600    $ 0.76
                                     
     Three Months Ended June 30, 2008    Six Months Ended June 30, 2008
     Net Income
(Numerator)
   Average
Shares
(Denominator)
   Per
Share
Amount
   Net Income
(Numerator)
   Average
Shares
(Denominator)
   Per
Share
Amount

Basic earnings per share:

                 

Income available to common shareholders

   $ 36,900    119,074    $ 0.31    $ 71,872    119,038    $ 0.60
                         

Effect of dilutive securities:

                 

Stock options, restricted stock and other plans

      852          784   

Stock purchase right

      213          193   
                             

Diluted earnings per share:

                 

Income available to common shareholders

   $ 36,900    120,139    $ 0.31    $ 71,872    120,015    $ 0.60
                                     

Metavante and WPM, L.P., a Delaware limited partnership (“WPM”) affiliated with Warburg Pincus LLC (collectively “Warburg Pincus”) entered into a Stock Purchase Right Agreement dated November 1, 2007. Under the Stock Purchase Right Agreement, Warburg Pincus has the right to purchase shares of Metavante common stock in order to maintain its interest in the common shares of Metavante. On August 21, 2008, Metavante and Warburg Pincus entered into an Amended and Restated Stock Purchase Right Agreement, which allows for net settlement of the quarterly purchase by Warburg Pincus. During the three and six months ended June 30, 2009, Warburg Pincus received 0 and 5 shares, respectively, of Metavante common stock under the Amended and Restated Stock Purchase Right Agreement. In connection with the proposed merger transaction with Fidelity National Information Services, Inc., discussed in Note 13 below, the Amended and Restated Stock Purchase Right Agreement was amended as of March 31, 2009.

The diluted earnings per share calculations for the three months ended June 30, 2009 and 2008 exclude stock options that are convertible into 1.5 million and 7.7 million common shares, respectively, because their inclusion would have been anti-dilutive. The diluted earnings per share calculations for the six months ended June 30, 2009 and 2008 exclude stock options that are convertible into 5.3 million and 7.8 million common shares, respectively, because their inclusion would have been anti-dilutive.

 

11


Table of Contents

METAVANTE TECHNOLOGIES, INC.

Notes to the Condensed Consolidated Financial Statements – continued (Unaudited)

(In thousands, except per share amounts)

 

9. Employee Retirement and Health Plans

Metavante sponsors a defined benefit health plan that provides health care benefits to eligible current and retired employees. Eligibility for retiree benefits is dependent upon age, years of service, and participation in the health plan during active service. Employees hired, including employees retained from mergers, after September 1, 1997, will be granted access to the plan upon retirement; however, such retirees must pay 100% of the cost of health care benefits. The plan continues to contain other cost-sharing features such as deductibles and coinsurance. Metavante intends to meet the benefit obligations of the defined benefit health plan through operating cash and does not intend to make contributions to the plan or intend for the plan to hold any assets.

The following table provides detail on Metavante’s net periodic benefit costs for the three and six months ended June 30, 2009 and 2008:

 

     Three Months Ended
June 30,
 
         2009             2008      

Service cost

   $ 148      $ 198   

Interest cost on accumulated postretirement benefit obligation (“APBO”)

     152        176   

Prior service amortization

     (77     (154
                

Net periodic postretirement benefit cost

   $ 223      $ 220   
                
     Six Months Ended
June 30,
 
     2009     2008  

Service cost

   $ 296      $ 293   

Interest cost on APBO

     304        261   

Prior service amortization

     (154     (154
                

Net periodic postretirement benefit cost

   $ 446      $ 400   
                

Benefit payments and expenses, net of participant contributions, for the three and six months ended June 30, 2009 and 2008, amounted to $0.

The funded status, which is the accumulated postretirement benefit obligations as of June 30, 2009 was as follows:

 

Total funded status, December 31, 2008

   $ (9,363

Service cost

     (296

Interest cost on APBO

     (304
        

Total funded status, June 30, 2009

   $ (9,963
        

10. Fair Value Measurements

Fair value measurements are classified and disclosed in one of the following categories:

Level I – Quoted prices are available in active markets for identical assets or liabilities as of the reporting date.

Level II – Pricing inputs are other-than quoted prices in active markets, which are either directly or indirectly observable as of the reporting date. Fair value is determined through the use of models or other valuation methodologies.

Level III – Pricing inputs are unobservable for the asset or liability and include situations where there is little, if any, market activity for the asset or liability. The inputs into the determination of fair value require significant management judgment or estimation.

In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, an investment’s level within the fair value hierarchy is based on the lowest level of input that is significant to the fair

 

12


Table of Contents

METAVANTE TECHNOLOGIES, INC.

Notes to the Condensed Consolidated Financial Statements – continued (Unaudited)

(In thousands, except per share amounts)

 

value measurement. Metavante’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the investment.

The investment in Firstsource discussed in Note 3 used quoted market prices from the NSE because Firstsource’s common stock is publicly traded. Metavante used observable forward interest rates as inputs to a valuation model to value the interest rate swaps. Metavante obtained third party quotes to value its long-term debt.

As permitted by SFAS 159, “The Fair Value Option for Financial Assets and Financial Liabilities, Including an Amendment of FASB Statement No. 115” (“SFAS 159”), Metavante chose not to measure its debt at fair value within its Condensed Consolidated Balance Sheets. The fair value of the long-term debt within the table below is to meet the disclosure requirements of FSP FAS 107-1 and APB 28-1. See Note 5 for additional information regarding the long-term debt.

The following table summarizes the valuation of Metavante’s assets and (liabilities) by the above SFAS 157 fair value hierarchy as of June 30, 2009:

 

     Total     Level I    Level II     Level III

Interest in common stock of Firstsource

   $ 43,631      $ 43,631    $ —        $ —  

Interest rate swaps

     (39,861     —        (39,861     —  

Long-term debt

     (1,589,875     —        (1,589,875     —  

The change in assets and liabilities measured at fair value for which Metavante has used Level III inputs was not material to Metavante’s financial statements for the six months ended June 30, 2009.

11. Segments

Metavante determines its operating segments based on the information utilized by the chief operating decision maker, Metavante’s Chief Executive Officer, to allocate resources and assess performance. Based on this information, Metavante has determined that it operates in two operating segments—the Financial Solutions Group (“FSG”) and the Payment Solutions Group (“PSG”). FSG offers a comprehensive suite of technology and business services that are critical to a financial institution’s ability to attract, expand and service existing and prospective customers. PSG offers a comprehensive suite of payment products and services, including credit, debit and prepaid debit card management and a national payments network in NYCE, as well as specialized solutions to facilitate government and healthcare payments. These reportable segments are strategic business units through which Metavante offers different products and services. Metavante evaluates the performance of segments based on their respective revenues and segment operating income, which excludes certain corporate costs, net interest expense and income taxes. During 2009, Metavante revised the methodology for allocating certain sales and marketing costs between the FSG segment and PSG segment. Segment reporting for all periods was adjusted to reflect this change. The change for the three months ended June 30, 2008, was a decrease to FSG expenses of $1,021 and a corresponding increase to PSG expenses. The change for the six months ended June 30, 2008, was a decrease to FSG expenses of $1,842 and a corresponding increase to PSG expenses. Total segment operating income for the three and six months ended June 30, 2008 did not change.

 

13


Table of Contents

METAVANTE TECHNOLOGIES, INC.

Notes to the Condensed Consolidated Financial Statements – continued (Unaudited)

(In thousands, except per share amounts)

 

     FSG    PSG    Total  

Three months ended June 30, 2009

        

Revenue

   $ 177,433    $ 262,831    $ 440,264   

Expenses

     124,881      175,022      299,903   
                      

Segment operating income

   $ 52,552    $ 87,809      140,361   
                

Net corporate/other expenses (1)

           (58,577

Noncontrolling interest (2)

           (608
              

Income before income taxes and noncontrolling interest

         $ 81,176   
              

Three months ended June 30, 2008, as adjusted

        

Revenue

   $ 164,196    $ 260,632    $ 424,828   

Expenses

     125,609      181,300      306,909   
                      

Segment operating income

   $ 38,587    $ 79,332      117,919   
                

Net corporate/other expenses (1)

           (59,185

Noncontrolling interest (2)

           (639
              

Income before income taxes and noncontrolling interest

         $ 58,095   
              
     FSG    PSG    Total  

Six months ended June 30, 2009

        

Revenue

   $ 344,566    $ 522,548    $ 867,114   

Expenses

     250,343      353,190      603,533   
                      

Segment operating income

   $ 94,223    $ 169,358      263,581   
                

Net corporate/other expenses (1)

           (118,005

Noncontrolling interest (2)

           (1,179
              

Income before income taxes and noncontrolling interest

         $ 144,397   
              

Six months ended June 30, 2008, as adjusted

        

Revenue

   $ 328,207    $ 521,185    $ 849,392   

Expenses

     251,623      360,596      612,219   
                      

Segment operating income

   $ 76,584    $ 160,589      237,173   
                

Net corporate/other expenses (1)

           (120,988

Noncontrolling interest (2)

           (939
              

Income before income taxes and noncontrolling interest

         $ 115,246   
              

 

(1) Net corporate/other expenses include human resource, legal, finance and accounting, shared-based compensation, acquisition intangible amortization, interest, various other unallocated overhead charges and costs with the proposed merger discussed in Note 13. These costs are not allocated to the segments when Metavante management evaluates segment performance.
(2) Noncontrolling interest is included within the PSG segment when Metavante management evaluates segment performance

12. Commitments and Contingencies

During its normal course of business, Metavante may be involved from time to time in litigation. Metavante recorded a reserve in the amount of $8,698 as of December 31, 2008, for the estimated exposure and legal fees related to a contractual dispute with a former customer. On June 3, 2009, Metavante prevailed at the trial court level on all counts before the court related to such dispute. As a result, Metavante reversed the remaining reserve of $5,506, net of legal fees incurred, related to

 

14


Table of Contents

METAVANTE TECHNOLOGIES, INC.

Notes to the Condensed Consolidated Financial Statements – continued (Unaudited)

(In thousands, except per share amounts)

 

the contractual dispute, which was recorded as a reduction of selling, general and administrative expenses in the Condensed Consolidated Statements of Income.

In November 2007, Metavante entered into an interest rate swap with Lehman Brothers Special Financing, Inc. (“LBSFI”), which subsequently filed for protection under Chapter 11 of the United States Bankruptcy Code, as amended. Metavante no longer considers the interest rate swap to be a derivative as defined by SFAS 133, because Metavante does not believe that LBSFI can perform its obligations relative to the net settlement feature of the interest rate swap. As a result, Metavante is accounting for the interest rate swap as a contingent liability in accordance with SFAS 5, “Accounting for Contingencies.” As of June 30, 2009 and December 31, 2008, Metavante recorded a liability in the amount of $13,833 and $6,577, respectively, for the estimated exposure related to this contingency.

On July 21, 2009, Metavante and Temenos Group AG (“Temenos”) announced that they had reached a settlement relating to the termination of their agreement to launch an advanced core banking platform based on Temenos Core Banking in the United States market. The settlement resolves all issues associated with the agreement. As part of the settlement, Metavante received a license to continue its use of the Customer Information Management functionality of Temenos Core Banking for the development of Metavante’s next-generation core technology. Also, all Temenos warrants previously owned by Metavante were forfeited as part of the settlement. The remaining value of $394 for the warrants that Metavante had recorded in other assets was expensed during the three months ended June 30, 2009.

13. Merger Agreement

On April 1, 2009, Metavante and Fidelity National Information Services, Inc. (“FIS”) announced that the boards of directors of both companies had approved a definitive agreement under which FIS will acquire Metavante. Under the terms of the agreement, Metavante shareholders will receive a fixed exchange ratio of 1.35 shares of FIS common stock for each share of Metavante common stock they own. The transaction is structured as a tax-free reorganization whereby Metavante will be merged with and into a newly formed subsidiary of FIS. In connection with the transaction, Metavante’s lenders have agreed to waive their change of control provisions and permit the merger to proceed. Completion of the merger remains subject to antitrust clearance in the United States, receipt of Metavante and FIS shareholder approvals, and other customary closing conditions. Metavante will hold a special meeting of its shareholders to vote on the approval of the merger agreement on September 4, 2009.

On June 19, 2009, Metavante and FIS each received a request for additional information and documentary material, often referred to as a “Second Request,” from the United States Department of Justice (“DOJ”) in connection with the proposed merger. The Second Request from the DOJ is a procedure in the regulatory process under the Hart-Scott-Rodino Antitrust Improvements Act of 1976. Metavante and FIS are working closely with the DOJ, cooperating fully with its review, and seeking to respond promptly. The merger is expected to close during the fourth quarter of 2009.

In connection with the transaction, certain provisions of Metavante’s credit facility will be amended. The credit agreement amendment will become effective upon the satisfaction and/or waiver of certain conditions, including the consummation of the transaction.

 

15


Table of Contents
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

General

In this quarterly report, references to “Metavante,” “the Company,” “our company,” “we,” “our,” “ours,” and “us” refer to Metavante Technologies, Inc. (which is sometimes referred to individually as “Metavante Technologies”), and its consolidated subsidiaries.

This quarterly report contains “forward-looking statements” intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include those that express a plan, belief, expectation, estimation, anticipation, intent, contingency, future development or similar expression, and can generally be identified as forward-looking because they include words such as “believes,” “anticipates,” “expects,” “should,” or words of similar importance. Statements that describe our objectives or goals are also forward-looking statements. The forward-looking statements included in this report involve significant risks and uncertainties, and a number of factors, both foreseen and unforeseen, that could cause actual results to differ materially from our current expectations. Factors relating to the pending merger with Fidelity National Information Services, Inc. that could cause actual results to differ materially includes the possibilities that: the companies may be unable to obtain shareholder or regulatory approvals required for the merger, problems may arise in successfully integrating the businesses of the two companies, the merger may involve unexpected costs, the combined company may be unable to achieve cost savings from synergies, and the businesses may suffer as a result of uncertainty surrounding the merger. Other factors that may affect our results include, among others, our debt level, restrictions and limitations in our credit facilities, our competitive industry, changes in customer demand for our products or services, disruptions and instability in the credit and financial markets, economic recession, general changes in economic conditions, risks of damage to our data centers or associated infrastructure, foreign currency fluctuations, intellectual property risks, effect of regulation on our business, network and operational risk, loss of significant customers and customer consolidation risks, risks associated with future acquisitions, and other factors discussed in Metavante’s Annual Report on Form 10-K under the heading “Risk Factors,” and other filings with the Securities and Exchange Commission. Shareholders, potential investors and other readers are urged to consider these factors carefully in evaluating the forward-looking statements. Readers are cautioned not to place undue reliance upon forward-looking statements, which speak only as of the date hereof. We undertake no obligation to update forward-looking statements to reflect events or circumstances occurring after the date hereof.

The following section discusses management’s view of the financial condition and results of operations of Metavante Technologies and its consolidated subsidiaries as of and for the three and six months ended June 30, 2009 and 2008.

Overview

Metavante delivers banking and payments technologies to approximately 8,000 financial services firms and businesses worldwide. Metavante products and services drive account processing for deposit, loan and trust systems, image-based and conventional check processing, electronic funds transfer, consumer healthcare payments, electronic presentment and payment transactions, outsourcing, and payment network solutions including the NYCE® Payment Network, an ATM/PIN debit network. Metavante’s results of operations are classified into two business segments: the Financial Solutions Group (“FSG”) and the Payment Solutions Group (“PSG”).

Metavante began operations in 1964, providing community and regional banks with dependable, outsourced account processing services with a high level of client service. Since then, Metavante has become a provider of innovative, high quality products and services to the financial services, commercial and healthcare insurance industries. Metavante’s overall strategy is to drive revenue and earnings growth by: (1) expanding core banking relationships; (2) expanding services provided to the large bank segment through dedicated relationship management teams focused on the top-50 United States financial institutions, the development of our next-generation global banking platform, and strong point solution product offerings; (3) focusing on emerging payment markets including expanded offerings within government and healthcare payments, and through the development of innovative payment offerings such as mobile financial services; and (4) expanding globally by leveraging existing offerings for international markets and international acquisitions.

Metavante’s revenue increased 4% for the three months ended June 30, 2009, compared with the three months ended June 30, 2008. Metavante’s net income for the three months ended June 30, 2009 was $51.9 million, compared to net income for the three months ended June 30, 2008 of $36.9 million. These results demonstrated the strength of Metavante’s business model and proactive efforts to manage the cost structure, in what continues to be a challenging environment for Metavante and its clients.

 

16


Table of Contents

Recent Developments

On April 1, 2009, Metavante and Fidelity National Information Services, Inc. (“FIS”) announced that the boards of directors of both companies had approved a definitive agreement under which FIS will acquire Metavante. Under the terms of the agreement, Metavante shareholders will receive a fixed exchange ratio of 1.35 shares of FIS common stock for each share of Metavante common stock they own. The transaction is structured as a tax-free reorganization whereby Metavante will be merged with and into a newly formed subsidiary of FIS. In connection with the transaction, Metavante’s lenders have agreed to waive their change of control provisions and permit the merger to proceed. Completion of the merger remains subject to antitrust clearance in the United States, receipt of Metavante and FIS shareholder approvals, and other customary closing conditions. Metavante will hold a special meeting of its shareholders to vote on the approval of the merger agreement on September 4, 2009.

On June 19, 2009, Metavante and FIS each received a request for additional information and documentary material, often referred to as a “Second Request,” from the United States Department of Justice (“DOJ”) in connection with the proposed merger. The Second Request from the DOJ is a procedure in the regulatory process under the Hart-Scott-Rodino Antitrust Improvements Act of 1976. Metavante and FIS are working closely with the DOJ, cooperating fully with its review, and seeking to respond promptly. The merger is expected to close during the fourth quarter of 2009.

Results of Operations

The following table shows the results of operations of Metavante for the three and six months ended June 30, 2009 and 2008 (in millions):

 

     Three Months Ended
June 30,
    Six Months Ended
June 30,
 

Selected Financial Information

   2009     2008     2009     2008  

Processing and services revenue

   $ 440.3      $ 424.8      $ 867.1      $ 849.4   

Expenses:

        

Cost of processing and services

     277.1        279.5        557.4        560.2   

Selling, general and administrative

     53.9        60.8        111.0        119.5   
                                

Total expenses

     331.0        340.3        668.4        679.7   
                                

Income from operations

     109.3        84.5        198.7        169.7   

Other non-operating income (expense):

        

Interest expense, net

     (28.3     (25.2     (54.4     (52.8

Net loss related to Firstsource

     —          (0.3     —          (0.9

Other

     0.2        (0.9     0.1        (0.7
                                

Income before income taxes and noncontrolling interest

     81.2        58.1        144.4        115.3   

Provision for income taxes

     29.9        21.8        53.5        44.3   
                                

Net income before noncontrolling interest

     51.3        36.3        90.9        71.0   

Noncontrolling interest

     0.6        0.6        1.2        0.9   
                                

Net income

   $ 51.9      $ 36.9      $ 92.1      $ 71.9   
                                

 

17


Table of Contents

Key Operating Metrics

Metavante management believes the results of operations expressed as a percentage of revenue provide insight into trends of the business. The following table shows the results of operations of Metavante for the three and six months ended June 30, 2009 and 2008, expressed as a percentage of revenue for the respective periods:

 

     Three Months Ended
June 30,
    Six Months Ended
June 30,
 

Selected Financial Information (% of Revenue)

   2009     2008     2009     2008  

Processing and services revenue

   100   100   100   100

Expenses:

        

Cost of processing and services

   62.9   65.8   64.3   65.9

Selling, general and administrative

   12.2   14.3   12.8   14.1
                        

Total expenses

   75.1   80.1   77.1   80.0
                        

Income from operations

   24.9   19.9   22.9   20.0

Other non-operating income (expense):

        

Interest expense, net

   (6.4 )%    (5.9 )%    (6.3 )%    (6.2 )% 

Net loss related to Firstsource

   0.0   (0.1 )%    0.0   (0.1 )% 

Other

   0.0   (0.2 )%    0.0   (0.1 )% 
                        

Income before income taxes and noncontrolling interest

   18.5   13.7   16.6   13.6

Provision for income taxes

   6.8   5.1   6.2   5.2
                        

Net income before noncontrolling interest

   11.7   8.6   10.4   8.4

Noncontrolling interest

   0.1   0.1   0.2   0.1
                        

Net income

   11.8   8.7   10.6   8.5
                        

Non-GAAP Financial Measures

Within this report, Metavante uses EBITDA, which is a non-GAAP financial measure. Metavante’s management believes this measure is useful for evaluating performance against peer companies within its industry, and provides investors with additional transparency to financial measures used by management in its financial and operational decision-making. Non-GAAP financial measures should not be considered a substitute for the reported results prepared in accordance with GAAP. Metavante’s definition used to calculate non-GAAP financial measures may differ from those used by other companies.

EBITDA is defined as net income before income taxes, interest expense net of interest income, depreciation and amortization. Metavante utilizes EBITDA in the evaluation and determination of the price of potential acquisition candidates, to explain trends in operating performance and to provide useful information about our ability to incur and service indebtedness. EBITDA also was included in the financial covenant within Metavante’s credit facility. In addition to the items noted above, EBITDA, as defined in the financial covenant in Metavante’s credit facility, also excludes certain non-cash charges, such as impairment charges and stock-based compensation expense.

EBITDA has limitations as an analytical tool and should not be considered a substitute for, or more meaningful than, income from operations, net income, cash flows from operating activities or other measures of financial performance prepared in accordance with GAAP. Some of these limitations are: (1) EBITDA does not reflect changes in, or cash requirements for, working capital needs; (2) EBITDA does not reflect interest expense, or the cash requirements necessary to service interest or principal payments, on debt; (3) EBITDA does not reflect income tax expense, or the cash requirements necessary to make income tax payments; and (4) although depreciation and amortization are non-cash charges, the assets being depreciated and amortized may have to be replaced in the future, and EBITDA does not reflect any cash requirements for such capital expenditures. Because of these limitations, EBITDA should not be considered as a principal indicator of Metavante’s performance. Metavante compensates for these limitations by relying primarily on GAAP results and using EBITDA only on a supplemental basis.

 

18


Table of Contents

The following table shows a reconciliation of net income to EBITDA for the three and six months ended June 30, 2009 and 2008 (in millions):

 

     Three Months Ended
June 30,
   Six Months Ended
June 30,
     2009    2008    2009    2008

Net income

   $ 51.9    $ 36.9    $ 92.1    $ 71.9

Add: Net interest expense

     28.3      25.2      54.4      52.8

Provision for income taxes

     29.9      21.8      53.5      44.3

Depreciation and amortization

     30.1      29.5      58.9      59.8

Acquisition intangible amortization

     7.3      7.6      14.7      14.9
                           

EBITDA

   $ 147.5    $ 121.0    $ 273.6    $ 243.7
                           

Description of Revenues and Expenses

Revenue

Metavante’s revenue consists primarily of the following:

Data Processing—Metavante generates a majority of its account and transaction processing fees on services provided under multi-year contracts, primarily with clients in the financial services industry. Various factors influence Metavante’s processing revenue stream including the retention of existing clients, each client’s organic growth, sales to new clients, cross-sales to existing clients, competition from other services providers and consolidation in the financial services industry (which can be either favorable or unfavorable depending on whether the client is an acquirer or is itself acquired). Certain divisions have seasonal patterns in their data processing revenue.

Software Licenses—Metavante licenses certain products to clients with in-house capabilities and a preference to manage these products directly versus outsourcing to Metavante in a hosted environment. Various factors influence Metavante’s software sales including product breadth and functionality, new product introductions, competitive pressures and price. Metavante’s software sales exhibit some seasonal patterns typical of the industry, such as relatively stronger quarter-end and year-end sales activity. In addition, software license sales can be unpredictable in nature, thereby creating large changes between periods.

Software Maintenance—The typical software license contract also includes a multi-year maintenance agreement entitling the licensee to support and updates, and generating additional annual revenue at a percentage of the license fee.

Professional Services—Metavante generates revenue from consulting, client support, training and the conversion of clients’ processing systems to Metavante’s processing system. Existing and new clients will contract for consulting or other services in conjunction with the Metavante account and transaction processing systems they use, or the Metavante licensed applications they run. Various factors influence Metavante’s professional services revenue including the size or complexity of the conversion or product implementation, competition by other consulting firms and price.

Other Revenue—Metavante generates additional revenue from the production of plastic debit, credit, stored value, health insurance, and transit cards, hardware sales in conjunction with software license contracts, certain pass-through charges, such as postage, and client termination fees. Other revenue may vary from period to period.

Expense

Metavante’s expense consists primarily of the following:

Cost of Processing and Services—Cost of processing and services expenses consist of the operational costs that support Metavante’s revenue generating activities. These costs include computer hardware, software and telecommunications expenses, as well as costs related to programming development and support, customer service, professional services and consulting, and other direct operating and management expenses associated with the delivery of services. It also includes the cost to purchase merchandise from suppliers for card production, hardware resale and various pass-through expenses.

Selling, General and Administrative—Selling, general and administrative expenses consist of salaries, benefits and other costs related to sales and marketing personnel, administrative employees and management, the costs of advertising and promotion, insurance, acquisition intangible amortization and other administrative costs.

 

19


Table of Contents

Comparison of the Three Months Ended June 30, 2009 and 2008

Revenue

Revenue increased $15.5 million, or 4%, to $440.3 million for the three months ended June 30, 2009, as compared to $424.8 million for the three months ended June 30, 2008. The revenue growth was primarily driven by data processing activity and client termination fees, which more than offset lower professional services and software license revenue.

Cost of Processing and Services

Cost of processing and services decreased $2.4 million, or 1%, to $277.1 million for the three months ended June 30, 2009, compared to $279.5 million for the three months ended June 30, 2008. Cost of processing and services, as a percentage of revenue, improved to 62.9% for the three months ended June 30, 2009, compared to 65.8% for the three months ended June 30, 2008. The decrease as a percentage of sales was due to cost productivity and advantageous revenue mix, primarily from client termination fees.

Selling, General and Administrative Expense

Selling, general and administrative expense decreased $6.9 million, or 11%, to $53.9 million for the three months ended June 30, 2009, compared to $60.8 million for the three months ended June 30, 2008. Selling, general and administrative expenses, as a percentage of revenue, decreased to 12.2% for the three months ended June 30, 2009, compared to 14.3% for the three months ended June 30, 2008. The decrease as a percentage of sales is due to cost productivity and the reversal of remaining reserve of $5.5 million related to litigation regarding a contractual dispute with a former customer because Metavante prevailed at the trial court level in such litigation. These items more than offset transaction costs of $4.5 million incurred in the second quarter of 2009 associated with the proposed FIS merger transaction.

Income from Operations

Income from operations increased $24.8 million, or 29%, to $109.3 million for the three months ended June 30, 2009, compared to $84.5 million for the three months ended June 30, 2008. Income from operations, as a percentage of revenue, was 24.9% for the three months ended June 30, 2009, compared to 19.9% for the three months ended June 30, 2008. The increase in operating margin was due to cost productivity and advantageous revenue mix, primarily from higher client termination fees.

Interest Expense, net

Interest expense, net of interest income, increased $3.1 million, to $28.3 million for the three months ended June 30, 2009, compared to $25.2 million for the three months ended June 30, 2008. The increase was due to the treatment of a de-designated cash flow hedge and lower interest income.

Net Loss Related to Firstsource

During the three months ended June 30, 2009, Metavante recorded no pre-tax losses related to Metavante’s investment in Firstsource Solutions Limited, compared to $0.3 million in pre-tax losses during the three months ended June 30, 2008. See Note 3 in the Notes to the Condensed Consolidated Financial Statements for further information.

Other Non-Operating Income (Expense)

Other non-operating income (expense) was $0.2 million for the three months ended June 30, 2009, compared to $(0.9) million for the three months ended June 30, 2008. Other non-operating income (expense) can vary between periods.

Provision for Income Taxes

The provision for income taxes was $29.9 million for the three months ended June 30, 2009, compared to $21.8 million for the three months ended June 30, 2008. The effective tax rate was 36.9% for the three months ended June 30, 2009, compared to 37.6% for the three months ended June 30, 2008. The effective tax rate was lower for the three months ended June 30, 2009 because the benefit of the federal research and experimentation credit was recorded. In 2008, the federal research and experimentation credit for 2008 was not extended until October 2008, therefore, the full-year benefit was recorded in the fourth quarter of 2008.

 

20


Table of Contents

Noncontrolling interest

Noncontrolling interest was $0.6 million for the three months ended June 30, 2009 and 2008. These amounts relate to the portion of losses that are attributable to the noncontrolling shareholders of the Everlink Payment Services, Inc. and Monitise Americas, LLC entities. These amounts can vary between periods depending on the performance of the respective businesses.

Net Income

Net income for the three months ended June 30, 2009 was $51.9 million compared to $36.9 million for the three months ended June 30, 2008 due to the reasons stated above.

Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)

EBITDA increased $26.5 million, or 22%, to $147.5 million for the three months ended June 30, 2009, compared to $121.0 million for the three months ended June 30, 2008. EBITDA as a percentage of revenue was 33.5% for the three months ended June 30, 2009, compared to 28.5% for the three months ended June 30, 2008. The increase in EBITDA, as a percentage of revenue was due to cost productivity and advantageous revenue mix.

Comparison of the Six Months Ended June 30, 2009 and 2008

Revenue

Revenue increased $17.7 million, or 2%, to $867.1 million for the six months ended June 30, 2009, as compared to $849.4 million for the six months ended June 30, 2008. The revenue growth was primarily driven by higher processing activity and client termination fees, which more than offset lower professional services and software license revenue.

Cost of Processing and Services

Cost of processing and services decreased $2.8 million, or 1%, to $557.4 million for the six months ended June 30, 2009, compared to $560.2 million for the six months ended June 30, 2008. Cost of processing and services, as a percentage of revenue, improved to 64.3% for the six months ended June 30, 2009, compared to 65.9% for the six months ended June 30, 2008. The decrease as a percentage of sales was due to cost productivity and advantageous revenue mix, primarily from higher client termination fees.

Selling, General and Administrative Expense

Selling, general and administrative expense decreased $8.5 million, or 7%, to $111.0 million for the six months ended June 30, 2009, compared to $119.5 million for the six months ended June 30, 2008. Selling, general and administrative expenses, as a percentage of revenue, decreased to 12.8% for the six months ended June 30, 2009, compared to 14.1% for the six months ended June 30, 2008. The decrease as a percentage of sales is due to cost productivity and the reversal of the remaining reserve of $5.5 million related to litigation regarding a contractual dispute with a former customer because Metavante prevailed at the trial court level in such litigation. These items more than offset transaction costs of $6.6 million in the six months ended June 30, 2009 associated with the proposed FIS merger transaction.

Income from Operations

Income from operations increased $29.0 million, or 17%, to $198.7 million for the six months ended June 30, 2009, compared to $169.7 million for the six months ended June 30, 2008. Income from operations, as a percentage of revenue, was 22.9% for the six months ended June 30, 2009, compared to 20.0% for the six months ended June 30, 2008. The increase in operating margin was due to cost productivity and advantageous revenue mix, primarily from higher client termination fees.

Interest Expense, net

Interest expense, net of interest income, increased $1.6 million, to $54.4 million for the six months ended June 30, 2009, compared to $52.8 million for the six months ended June 30, 2008. The amortization of a de-designated cash flow hedge increased net interest expense $1.6 million for the six months ended June 30, 2009 compared to the six months ended June 30, 2008.

 

21


Table of Contents

Net Loss Related to Firstsource

During the six months ended June 30, 2009, Metavante recorded no pre-tax losses related to Metavante’s investment in Firstsource Solutions Limited, compared to $0.9 million in pre-tax losses during the six months ended June 30, 2008. See Note 3 in the Notes to the Condensed Consolidated Financial Statements for further information.

Other Non-Operating Income (Expense)

Other non-operating income (expense) was $0.1 million for the six months ended June 30, 2009, compared to $(0.7) million for the six months ended June 30, 2008. Other non-operating income (expense) can vary between periods.

Provision for Income Taxes

The provision for income taxes was $53.5 million for the six months ended June 30, 2009, compared to $44.3 million for the six months ended June 30, 2008. The effective tax rate was 37.0% for the six months ended June 30, 2009, compared to 38.4% for the six months ended June 30, 2008. The effective tax rate was lower for the six months ended June 30, 2009 because the benefit of the federal research and experimentation credit was recorded. In 2008, the federal research and experimentation credit for 2008 was not extended until October 2008, therefore, the full-year benefit was recorded in the fourth quarter of 2008.

Noncontrolling interest

Noncontrolling interest was $1.2 million for the six months ended June 30, 2009, compared to $0.9 million for the six months ended June 30, 2008. These amounts relate to the portion of losses that are attributable to the noncontrolling shareholders of the Everlink Payment Services, Inc. and Monitise Americas, LLC entities. These amounts can vary between periods depending on the performance of the respective businesses.

Net Income

Net income for the six months ended June 30, 2009 was $92.1 million compared to $71.9 million for the six months ended June 30, 2008 due to the reasons stated above.

Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)

EBITDA increased $29.9 million, or 12%, to $273.6 million for the six months ended June 30, 2009, compared to $243.7 million for the six months ended June 30, 2008. EBITDA as a percentage of revenue was 31.6% for the six months ended June 30, 2009, compared to 28.7% for the six months ended June 30, 2008. The increase in EBITDA, as a percentage of revenue was due to cost productivity and advantageous revenue mix, primarily from higher client termination fees.

Business Segments

Metavante provides a full array of technology products and services for the financial services industry. Metavante’s results of operations are classified into two business segments: FSG and PSG. FSG and PSG are strategic business units through which Metavante offers different products and services. During 2009, Metavante revised the methodology for allocating certain sales and marketing costs between the FSG segment and PSG segment. Segment reporting for all periods was adjusted to reflect this change. The change for the three months ended June 30, 2008, was a decrease to FSG expenses of $1,021 and a corresponding increase to PSG expenses. The change for the six months ended June 30, 2008, was a decrease to FSG expenses of $1,842 and a corresponding increase to PSG expenses. Total segment operating income for the three and six months ended June 30, 2008 did not change. A further description of each of our business segments along with the corporate services area follows:

FSG—The Financial Solutions Group includes the following solution sets: banking, commercial treasury, eBanking, risk and compliance, sales and service and wealth management. FSG offers a comprehensive suite of technology and business services that are critical to a financial institution’s ability to attract, expand and service existing and prospective customers.

PSG—The Payment Solutions Group includes the following solution sets: acquiring, issuing, image, payment network, ePayment and healthcare payment. PSG offers a comprehensive suite of payment products and services, including credit, debit and prepaid card management and national payments networks in NYCE, as well as specialized solutions to facilitate government and heathcare payments.

 

22


Table of Contents

Corporate—Net corporate/other expenses include human resources, legal, finance and accounting, share-based compensation, acquisition intangible amortization, interest, various other unallocated overhead charges and costs associated with the proposed FIS merger transaction. These costs are not allocated to the segments when Metavante management evaluates segment performance.

Metavante evaluates the performance of its segments based on their respective revenues and segment operating income. The following table shows summarized financial information for each of Metavante’s two business segments for the three and six months ended June 30, 2009 and 2008 (in millions):

 

     FSG    PSG    Total  

Three months ended June 30, 2009

        

Revenue

   $ 177.5    $ 262.8    $ 440.3   

Expenses

     124.9      175.0      299.9   
                      

Segment operating income

   $ 52.6    $ 87.8      140.4   
                

Net corporate/other expenses

           (58.6

Noncontrolling interest (1)

           (0.6
              

Income before income taxes

         $ 81.2   
              

Three months ended June 30, 2008, as adjusted

        

Revenue

   $ 164.2    $ 260.6    $ 424.8   

Expenses

     125.6      181.3      306.9   
                      

Segment operating income

   $ 38.6    $ 79.3      117.9   
                

Net corporate/other expenses

           (59.2

Noncontrolling interest (1)

           (0.6
              

Income before income taxes

         $ 58.1   
              
     FSG    PSG    Total  

Six months ended June 30, 2009

        

Revenue

   $ 344.6    $ 522.5    $ 867.1   

Expenses

     250.3      353.2      603.5   
                      

Segment operating income

   $ 94.3    $ 169.3      263.6   
                

Net corporate/other expenses

           (118.0

Noncontrolling interest (1)

           (1.2
              

Income before income taxes

         $ 144.4   
              

Six months ended June 30, 2008, as adjusted

        

Revenue

   $ 328.2    $ 521.2    $ 849.4   

Expenses

     251.6      360.7      612.3   
                      

Segment operating income

   $ 76.6    $ 160.5      237.1   
                

Net corporate/other expenses

           (120.9

Noncontrolling interest (1)

           (0.9
              

Income before income taxes

         $ 115.3   
              

 

  (1) Noncontrolling interest is included within the PSG segment when Metavante management evaluates segment performance.

Comparison of the Three Months Ended June 30, 2009 and 2008

Revenue

Revenue for the FSG segment increased $13.3 million, or 8%, to $177.5 million for the three months ended June 30, 2009, compared to $164.2 million for the three months ended June 30, 2008. Revenue growth was driven primarily by higher client termination fees. In addition, higher core processing activity offset a decrease in professional services revenue.

 

23


Table of Contents

Revenue for the PSG segment increased $2.2 million, or 1%, to $262.8 million for the three months ended June 30, 2009, compared to $260.6 million for the three months ended June 30, 2008. The revenue increase was due to higher transaction volumes, which were offset by lower software license revenue and professional services revenue.

Segment Operating Income

Segment operating income for the FSG segment increased $14.0 million, or 36%, to $52.6 million for the three months ended June 30, 2009, compared to $38.6 for the three months ended June 30, 2008. Segment operating margin was 29.6% in 2009 compared to 23.5% in 2008. The increase in operating margin was due to advantageous revenue mix, particularly from higher client termination fees and cost productivity.

Segment operating income for the PSG segment increased $8.5 million, or 11%, to $87.8 million for the three months ended June 30, 2009, compared to $79.3 million for the three months ended June 30, 2008. Segment operating margin was 33.4% in 2009 compared to 30.4% in 2008. The increase in operating margin was primarily due to cost productivity.

Net corporate/other expenses decreased $0.6 million to $58.6 million for the three months ended June 30, 2009, compared to $59.2 million for the three months ended June 30, 2008. The decrease in net corporate/other expenses is primarily due to cost productivity and the reversal of the remaining reserve of $5.5 million related to litigation regarding a contractual dispute with a former customer because Metavante prevailed at the trial court level in such litigation. These items offset transaction costs incurred in the second quarter of 2009 associated with the proposed FIS merger transaction.

Comparison of the Six Months Ended June 30, 2009 and 2008

Revenue

Revenue for the FSG segment increased $16.4 million, or 5%, to $344.6 million for the six months ended June 30, 2009, compared to $328.2 million for the six months ended June 30, 2008. Revenue growth was driven by higher core processing activity and client termination fees, which were offset by lower professional services revenue.

Revenue for the PSG segment increased $1.3 million, to $522.5 million for the six months ended June 30, 2009, compared to $521.2 million for the six months ended June 30, 2008. The revenue increase was due to higher transaction volumes, which were offset by lower software license revenue.

Segment Operating Income

Segment operating income for the FSG segment increased $17.7 million, or 23%, to $94.3 million for the six months ended June 30, 2009, compared to $76.6 for the six months ended June 30, 2008. Segment operating margin was 27.4% in 2009 compared to 23.3% in 2008. The increase in operating margin was due to advantageous revenue mix, particularly higher client termination fees, and cost productivity.

Segment operating income for the PSG segment increased $8.8 million, or 5%, to $169.3 million for the six months ended June 30, 2009, compared to $160.5 million for the six months ended June 30, 2008. Segment operating margin was 32.4% in 2009 compared to 30.8% in 2008. The increase in operating margin was due to cost productivity.

Net corporate/other expenses decreased $2.9 million to $118.0 million for the six months ended June 30, 2009, compared to $120.9 million for the six months ended June 30, 2008. The decrease in net corporate/other expenses is primarily due to cost productivity and the reversal of the remaining reserve of $5.5 million related to litigation regarding a contractual dispute with a former customer because Metavante prevailed at the trial court level in such litigation. These items offset transaction costs incurred in the six months ended June 30, 2009 associated with the proposed FIS merger transaction.

 

24


Table of Contents

Liquidity and Capital Resources

Metavante broadly defines liquidity as its ability to generate sufficient cash flow from operating activities to meet its obligations and commitments. In addition, liquidity includes the ability to obtain appropriate debt and equity financing.

The following table shows Metavante’s sources and uses of funds for the six months ended June 30, 2009 and 2008 (in millions):

 

     Six months Ended
June 30,
 
     2009     2008  

Net cash from operating activities

   $ 170.5      $ 148.3   

Net cash from investing activities

     112.5        (209.1

Net cash from financing activities

     (189.9     73.7   

Effect of exchange rate changes on cash and cash equivalents

     0.7        (0.7
                

Change in cash and cash equivalents

   $ 93.8      $ 12.2   
                

Net cash from operating activities

Net cash from operating activities during the six months ended June 30, 2009 increased by $22.2 million to $170.5 million, compared to $148.3 million during the six months ended June 30, 2008. The increase was driven by an increase in net income of $20.2 million, which Metavante converted into cash from operating activities. The remaining increase was due to the timing of working capital items.

Net cash from investing activities

Net cash from investing activities during the six months ended June 30, 2009 increased by $321.6 million to a cash inflow of $112.5 million, compared to a cash outflow of $209.1 million during the six months ended June 30, 2008. The funds from processing certain types of transactions as described in Note 1 of the Notes to the Consolidated Financial Statements, in Item 8 of Metavante’s Annual Report on Form 10-K for the year ended December 31, 2008, increased $261.2 million for the six months ended June 30, 2009 compared to 2008. This amount can vary significantly from period to period. In addition, net cash from investing activities was impacted by a decrease in funds used for acquisitions of $57.3 million for the six months ended June 30, 2009, compared to the six months ended June 30, 2008.

Net cash from financing activities

Net cash from financing activities for the six months ended June 30, 2009 decreased $263.6 million to a cash outflow of $189.9 million, compared to a cash inflow of $73.7 million for the six months ended June 30, 2008. The decrease was primarily attributable to the change in processing certain types of transactions as described in Note 1 of the Notes to the Consolidated Financial Statements, in Item 8 of Metavante’s Annual Report on Form 10-K for the year ended December 31, 2008. The amount can vary significantly from period to period and decreased by $264.4 million for the six months ended June 30, 2009 compared to the six months ended June 30, 2008.

Free Cash Flow

Within this report, Metavante uses free cash flow as a non-GAAP financial measure. Metavante evaluates its liquidity in part based upon its free cash flow, defined as cash provided by operating activities less capital expenditures. Metavante’s management believes that free cash flow provides useful information to investors regarding Metavante’s ability to generate cash from business operations that is available for acquisitions, other investments and debt service. Non-GAAP financial measures should not be considered a substitute for the reported results prepared in accordance with GAAP. Free cash flow should not be considered as a principal indicator of Metavante’s performance. Metavante uses free cash flow only on a supplemental basis. Metavante’s definition of free cash flow may differ from definitions used by other companies.

 

25


Table of Contents

The following is a reconciliation of cash provided from operating activities to free cash flow (in millions):

 

     Six Months Ended
June 30,
     2009    2008

Net cash from operating activities

   $ 170.5    $ 148.3

Less capital expenditures:

     

Premises and equipment

     11.9      9.4

Software and conversions

     50.8      56.4
             

Free cash flow

   $ 107.8    $ 82.5
             

Free cash flow increased $25.3 million, or 31%, to $107.8 million for the six months ended June 30, 2009, compared to $82.5 million for the six months ended June 30, 2008. The increase was driven by an increase in net income of $20.2 million, which Metavante converted into cash from operating activities. The remaining increase was due to the timing of working capital items.

Credit Facilities

Except as set forth below, there have been no significant changes to Metavante’s credit facilities since the filing of our Annual Report on Form 10-K for the year ended December 31, 2008.

Following the execution of the merger agreement with FIS, on April 30, 2009, Metavante and its wholly owned subsidiary, Metavante Corporation (the “Borrower”), entered into an amendment (the “Credit Agreement Amendment”) to the credit agreement, originally entered into as of November 1, 2007, among Metavante, the Borrower, JPMorgan Chase Bank, N.A., as Administrative Agent, Lehman Commercial Paper Inc. and Baird Financial Corporation, as Documentation Agents, Morgan Stanley Senior Funding Inc., as Syndication Agent, and the lenders party thereto (the “Credit Agreement”). Lenders holding more than 90% of the outstanding amount of indebtedness under the Credit Agreement have consented to and executed the Credit Agreement Amendment (such lenders, the “Consenting Lenders”).

The Credit Agreement Amendment provides, among other things, that on its effective date, the outstanding indebtedness under the Credit Agreement will be restructured as follows: (i) the Borrower will borrow 100% of the unused revolving commitments under the Credit Agreement on or prior to such effective date, (ii) FIS or one of its subsidiaries will purchase all of the revolving loans of each Consenting Lender outstanding on such effective date if and only if such Consenting Lender commits to purchase accounts receivable from FIS’s securitization vehicle under a new FIS accounts receivable securitization facility to be entered into on or prior to the closing of the merger, (iii) an aggregate principal amount of $500.0 million of term loans held by the Consenting Lenders will be exchanged for an identical principal amount of term loans under FIS’s existing credit facility, (iv) FIS or one of its subsidiaries will purchase up to an aggregate principal amount of $428.1 million of the remaining term loans held by the Consenting Lenders at par in cash, (v) if, after giving effect to the debt exchange and purchases described in the foregoing clauses (ii), (iii) and (iv), the aggregate principal amount of term loans and revolving loans that remain outstanding under the Credit Agreement (as amended by the Credit Agreement Amendment) would result in a “default” under the FIS’s existing credit agreement, the Borrower will prepay these loans on a pro rata basis for the relevant credit facility in a minimum amount necessary to avoid such “default” and (vi) the term loans that remain outstanding under the Credit Agreement after giving effect to the transactions described in the foregoing clauses (iii), (iv) and (v) will be re-priced as provided in the Credit Agreement Amendment (the transactions described in the foregoing clauses (i) through (vi), collectively, the “Restructuring Transactions”). The term loans and revolving loans purchased or exchanged by FIS or one of its subsidiaries pursuant to the Restructuring Transactions will be deemed immediately cancelled for all purposes of the Credit Agreement and no longer outstanding.

As previously reported, the requisite lenders under the Credit Agreement have agreed to waive their change of control provisions and permit the merger and related transactions to proceed.

The Credit Agreement Amendment also amends certain covenants and other provisions in the Credit Agreement to permit the consummation of the Restructuring Transactions and to conform to the covenants in FIS’s existing credit facility. The Credit Agreement Amendment will become effective upon the satisfaction and/or waiver of certain conditions set forth therein, including the consummation of the merger.

In consideration of the Consenting Lenders entering into the Credit Agreement Amendment, the Borrower will pay to the administrative agent for the ratable account of the Consenting Lenders a fee equal to 1.00% of the aggregate amount of the term loans or revolving commitments held by such lenders immediately prior to the Restructuring Transactions.

 

26


Table of Contents

In connection with the Restructuring Transactions, Metavante and the Borrower and their subsidiaries that are guarantors under the Credit Agreement will be required to guarantee the obligations under FIS’s credit facility and its new accounts receivable securitization facility referred to above.

As of June 30, 2009, Metavante was subject to a consolidated leverage ratio covenant. The consolidated leverage ratio is the ratio of consolidated total net debt to credit agreement EBITDA. As of June 30, 2009, the ratio must not exceed 4.25:1.00. Metavante’s consolidated leverage ratio as of June 30, 2009 was 2.5:1:00. As of June 30, 2009, Metavante was in compliance with all covenants within its credit facilities. See our Annual Report on Form 10-K for the year ended December 31, 2008 for additional information regarding sources of liquidity.

Metavante believes that its existing cash balances, future cash flows from operations and borrowing programs will provide adequate sources of liquidity and capital resources to meet Metavante’s expected short-term liquidity needs and its long-term needs for operations of its business, expected capital spending for the next 12 months and the foreseeable future and the satisfaction of its obligations and commitments.

Contractual Obligations

There have been no significant changes to Metavante’s contractual obligations from those disclosed in our Annual Report on Form 10-K for the year ended December 31, 2008.

Off-Balance Sheet Financing Arrangements

At June 30, 2009, Metavante had no off-balance sheet arrangements.

Critical Accounting Policies

There have been no significant changes to Metavante’s critical accounting policies since the filing of our Annual Report on Form 10-K for the year ended December 31, 2008.

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

Metavante’s quantitative and qualitative disclosures about market risk have not materially changed since the filing of our Annual Report on Form 10-K for the year ended December 31, 2008.

 

Item 4. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

Metavante carried out an evaluation, under the supervision and with the participation of management, including Metavante’s Chief Executive Officer and its Chief Financial Officer, of the effectiveness, as of June 30, 2009, of the design and operation of the disclosure controls and procedures, as defined in Rule 13a-15(e) of the Securities Exchange Act of 1934, as amended. Based upon that evaluation, Metavante’s Chief Executive Officer and its Chief Financial Officer have concluded that the disclosure controls and procedures were effective as of June 30, 2009.

Changes in Internal Control over Financial Reporting

There has been no change in Metavante’s internal control over financial reporting during the quarter ended June 30, 2009 that has materially affected, or is reasonably likely to materially affect, Metavante’s internal control over financial reporting.

 

27


Table of Contents

PART II. OTHER INFORMATION

 

Item 1A. Risk Factors.

See “Risk Factors” in Part 1 – Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2008 for information about risk factors. There have been no material changes in our risk factors from those disclosed in our Annual Report on Form 10-K for the year ended December 31, 2008, other than the risk factors updated in Part II – Item 1A of our Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2009.

 

Item 5. Other Information.

Litigation Related to the Merger

On April 7, 2009, a putative class action complaint was filed by a purported Metavante shareholder against Metavante, its directors, certain officers, and FIS. The complaint alleges that the directors and officers breached fiduciary duties to Metavante shareholders and that Metavante and FIS aided and abetted such breaches. The complaint seeks to enjoin the proposed merger transaction, preliminarily and permanently, and also seeks damages, attorneys’ fees, and class certification. An amended complaint was filed on April 23, 2009, adding an additional plaintiff, but it is otherwise the same as the original complaint. A second amended complaint was filed on May 15, 2009. The second amended complaint added, inter alia, a claim against Metavante and FIS for an alleged breach of duty of full and fair disclosure, based on allegations that the Form S-4 filed by FIS on May 4, 2009 fails to disclose relevant material information about the proposed merger transaction. The case is Lisa Repinski, et al v. Michael Hayford, et al, Milwaukee County Circuit Court Case No. 09CV5325.

On April 24, 2009, a second putative class action concerning similar allegations was filed by another purported Metavante shareholder against Metavante and its directors and certain officers. This complaint also seeks to enjoin the transaction, preliminarily and permanently, and also seeks damages, attorneys’ fees, and class certification. An amended complaint was filed on May 15, 2009. The amended complaint purported to add FIS as a defendant, as well as certain allegations substantively similar to those contained in the second amended complaint filed in the Repinski action. The case is Samuel Beren v. Metavante Technologies, Inc. et al., Milwaukee County Circuit Court Case No. 09CV6315.

On June 1, 2009, Judge Jean W. DiMotto signed an order consolidating the Repinski and Beren actions as In re Metavante Technologies, Inc. Shareholder Litigation, No. 09CV5325. The second amended complaint in the Repinski action was designated the operative complaint in the consolidated action. FIS and Metavante believe these actions are without merit and intend to defend themselves vigorously against the claims.

 

Item 6. Exhibits.

See the Exhibit Index following the signatures page of this report, which is incorporated herein by reference.

 

28


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  METAVANTE TECHNOLOGIES, INC.
                      (Registrant)
Date: August 5, 2009   /s/    TIMOTHY C. OLIVER        
  Timothy C. Oliver
  Senior Executive Vice President and
  Chief Financial Officer
  (Principal Financial Officer and Duly Authorized Officer)
Date: August 5, 2009   /s/    KENNETH F. BEST        
  Kenneth F. Best
  Principal Accounting Officer
  (Principal Accounting Officer and Duly Authorized Officer)

 

29


Table of Contents

METAVANTE TECHNOLOGIES, INC.

(the “Registrant”)

(Commission File No. 001-33747)

Exhibit Index

to

Quarterly Report on Form 10-Q

for the Quarter Ended June 30, 2009

 

Exhibit
No.

  

Description

  

Incorporated Herein

by Reference to

   Filed
Herewith

  4.1

   Amendment No. 1 to Credit Agreement, dated April 30, 2009, among Metavante Technologies, Inc., Metavante Corporation, the lenders party thereto, and JP Morgan Chase Bank, N.A., as administrative agent.    Exhibit 4.1 to the Registrant’s Current Report on Form 8-K filed on May 1, 2009.   

31.1

   Certification Pursuant to Rule 13a-14(a) or 15d-14(a), as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.       X

31.2

   Certification Pursuant to Rule 13a-14(a) or 15d-14(a), as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.       X

32.1

   Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.       X

32.2

   Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.       X

 

30

Certification Pursuant to Section 302

Exhibit 31.1

CERTIFICATION

I, Frank R. Martire, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of Metavante Technologies, Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

/S/    FRANK R. MARTIRE        

Frank R. Martire
Chief Executive Officer

August 5, 2009

Certification Pursuant to Section 302

Exhibit 31.2

CERTIFICATION

I, Timothy C. Oliver, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of Metavante Technologies, Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

/S/    TIMOTHY C. OLIVER        

Timothy C. Oliver
Chief Financial Officer

August 5, 2009

Certification Pursuant to Section 906

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Metavante Technologies, Inc. (the “Company”) on Form 10-Q for the period ended June 30, 2009, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Frank R. Martire, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

/S/    FRANK R. MARTIRE        
Frank R. Martire
Chief Executive Officer

August 5, 2009

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

Certification Pursuant to Section 906

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Metavante Technologies, Inc. (the “Company”) on Form 10-Q for the period ended June 30, 2009, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Timothy C. Oliver, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

/S/    TIMOTHY C. OLIVER        
Timothy C. Oliver
Chief Financial Officer

August 5, 2009

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.